Matheus Pileggi Camargo

Matheus Pileggi Camargo

Auto-generated profile, based on publicly available information

Matheus Pileggi Camargo

Faculdade de Ciencias Médicas da Santa Casa de São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Coluna/Columna
Verified
Journal Article
Open access
TLThomas Yi Teh Lee
Thomas Yi Teh Lee
MCMatheus Pileggi Camargo
Matheus Pileggi Camargo
LSLuana Caroline Kfouri Siqueira
Luana Caroline Kfouri Siqueira
WMWesley Wilian Costa Martins
Wesley Wilian Costa Martins
LSLeonardo Sardas
Leonardo Sardas
RMRobert Meves
Robert Meves
Objective: To describe the clinical profile and postoperative outcomes of patients undergoing instrumented spinal arthrodesis under a preemptive antibiotic therapy protocol with vancomycin and ciprofloxacin. Methods: A retrospective, consecutive, and single-center case series was conducted involving 88 patients operated on between January 2021 and December 2022. The protocol consisted of intravenous vancomycin (1 g) and ciprofloxacin (400 mg) administered 60 minutes before incision, with postoperative maintenance for five days. The minimum clinical follow-up was 24 months. Results: The mean age was 45.2 years, with a male predominance (60.2%). Trauma was the most frequent surgical indication (38.9%), followed by neoplasms (25%). The overall arthrodesis infection rate was 4.5% (4/88 patients), with 75% of these cases occurring in patients with oncological etiology. Only one adverse event (1.1%) related to vancomycin was recorded. Conclusions: The preemptive antibiotic therapy protocol showed favorable infection rates (4.5%) and good pharmacological tolerability in the studied sample, suggesting it is a viable strategy for high-complexity spine surgeries. Level of Evidence IV; Case series.